From PCOS to PMOS: Why Polycystic Ovary Syndrome Is Fundamentally a Metabolic Disease

For decades, millions of women who received a diagnosis of Polycystic Ovary Syndrome (PCOS) were given a very narrow explanation of their condition: they were told that their ovaries were covered in “cysts,” that their irregular periods meant they might struggle with fertility, and that the primary solution was to take a oral contraceptive pill until they were ready to conceive.

However, clinical research and reproductive endocrinology have increasingly exposed a major flaw in this traditional narrative: the name “Polycystic Ovary Syndrome” is a profound medical misnomer. The fluid-filled structures seen on ovarian ultrasounds are not actual anatomical cysts at all, nor are ovarian symptoms the primary cause of the condition. Instead, leading medical experts, research bodies, and advocacy groups are pushing to reframe the disease as PMOS (Primary Metabolic Ovarian Syndrome) or Polymetabolic Ovarian Syndrome.

Understanding the conceptual evolution from PCOS and PMOS is more than just a debate over medical terminology. For Black women—who experience higher rates of insulin resistance, cardiovascular risks, and delayed diagnoses—going from PCOS to PMOS is a shift in diagnostic understanding changes how the disease is tested, managed, and treated at its root cause.

The Problem with the Name “PCOS”

To understand how we went from PCOS to PMOS it first helps to understand that the term “Polycystic Ovary Syndrome” originated in 1935 when doctors Irving Stein and Michael Leventhal identified a cluster of symptoms—hirsutism (excess body hair), irregular cycles, obesity, and enlarged ovaries—which they termed Stein-Leventhal Syndrome. Decades later, the condition was renamed PCOS, solidifying the idea in both clinical medicine and public consciousness that this was strictly a gynecological disorder centered in the ovaries.

Why “Polycystic” Is Misleading:

1. They Are Not Cysts: The “cysts” described in PCOS are actually small, undeveloped fluid-filled sacs called immature follicles. Under normal circumstances, several follicles begin maturing during the follicular phase of the menstrual cycle, and one dominant follicle ruptures to release an egg (ovulation). In PCOS, hormone signaling stalls, causing dozens of partially developed follicles to rest on the outer edge of the ovary—creating a classic “string of pearls” appearance on an ultrasound.
2. You Don’t Need “Cysts” to Have the Condition: Under the widely accepted Rotterdam Diagnostic Criteria established by the National Institutes of Health (NIH), a patient only needs to meet two out of three criteria: irregular or absent periods, elevated androgen levels (hyperandrogenism), or polycystic ovarian morphology on an ultrasound. This means up to 30% of women diagnosed with the condition have completely normal-looking ovaries on an ultrasound.
3. Misdirected Medical Care: Focusing exclusively on the ovaries leads many providers to ignore systemic metabolic markers. Patients are frequently told, “Your ultrasound looks fine, so you don’t have PCOS,” or conversely, are prescribed hormonal birth control to mask irregular bleeding without ever addressing the underlying metabolic drivers.

Why PMOS (Primary Metabolic Ovarian Syndrome) Fits Better

Reframing PCOS and PMOS centers the true engine of the condition: hyperinsulinemia and insulin resistance.

In healthy endocrine function—as explored in our foundational guide on women’s hormones and health—the pancreas produces insulin to move glucose from the bloodstream into cells for energy. In PMOS, the body’s peripheral cells (primarily muscle and fat tissue) become resistant to insulin’s signals. To compensate, the pancreas pumps out increasingly higher levels of insulin into the bloodstream.

While your peripheral muscles may be resistant to insulin, your ovaries remain intensely sensitive to it. High levels of circulating insulin act as a direct co-gonadotropin on the ovaries, causing two major disruptions:

1. Excess Ovarian Androgen Production

High insulin levels stimulate the theca cells within the ovaries to overproduce testosterone and other androgens. Excess testosterone disrupts the delicate maturation of ovarian follicles, halting ovulation and leading to irregular or absent periods. To learn more about identifying irregular cycle patterns, review our guide on 5 ways to tell if your period is actually normal.

2. Suppression of Sex Hormone-Binding Globulin (SHBG)

Insulin signals the liver to decrease its production of Sex Hormone-Binding Globulin (SHBG)—a carrier protein that binds to excess sex hormones in the bloodstream. When SHBG drops, more testosterone circulates as “free,” unbound androgen, driving physical symptoms like cystic acne along the jawline, androgenic hair thinning, and facial hair growth (hirsutism).

The Systemic Impact: Beyond the Reproductive System

When viewed through the lens of PCOS and PMOS, it becomes clear that reproductive symptoms are merely downstream manifestations of a systemic metabolic disorder. Research published by the Endocrine Society highlights that metabolic dysfunction in PMOS impacts multiple physiological systems:

• Cardiovascular and Metabolic Risks: Women with PMOS have a significantly higher baseline risk of developing Type 2 diabetes, metabolic syndrome, non-alcoholic fatty liver disease (NAFLD), hypertension, and dyslipidemia (elevated triglycerides and low HDL cholesterol).
• Gut Health and Recirculating Inflammation: Insulin resistance and high androgen levels alter the gut microbiome, driving intestinal permeability and disrupting how the body clears used hormones—a process detailed in our overview of the estrobolome and estrogen clearance.
• Iron Depletion and Heavy Menstrual Bleeding: When anovulatory cycles occasionally result in prolonged or heavy breakthrough bleeding, chronic blood loss can cause severe iron deficiency, as discussed in our guide on heavy periods and anemia.
• Central Nervous System and Mood Disorders: Fluctuating blood sugar levels, systemic low-grade inflammation, and high androgen levels increase susceptibility to anxiety, depression, and severe chronic fatigue.

Shifting Treatment: From Band-Aids to Root-Cause Care in PCOS and PMOS

Transitioning from a “PCOS” mindset to a “PMOS” approach fundamentally changes how treatment is structured. Rather than relying solely on synthetic hormones to force a withdrawal bleed, evidence-based PMOS care focuses on improving insulin sensitivity, reducing systemic inflammation, and supporting long-term metabolic health.

1. Comprehensive Metabolic Testing

Instead of relying solely on a pelvic ultrasound, demand a complete metabolic and endocrine blood panel from your doctor:

• Fasting Insulin and Fasting Glucose: (Used to calculate your HOMA-IR score for insulin resistance).
• Hemoglobin A1c (HbA1c): Evaluates average blood sugar control over the past three months.
• Full Lipid Panel: Measures triglycerides, LDL, and HDL cholesterol.
• Comprehensive Androgen Panel: Tests Total and Free Testosterone, DHEA-S, and SHBG.

2. Insulin-Sensitizing Therapeutics and Supplements

• Metformin: A widely researched, evidence-based prescription medication that improves insulin sensitivity in the liver and peripheral tissues, lowering circulating insulin and reducing ovarian androgen synthesis.
• Inositol (Myo-Inositol & D-Chiro-Inositol): A naturally occurring B-vitamin-like compound that acts as an intracellular second messenger for insulin. Clinical trials show that a 40:1 ratio of Myo-Inositol to D-Chiro-Inositol improves ovulation rates, reduces insulin resistance, and lowers hyperandrogenism.
• Targeted Nutritional Approaches: Rather than adopting hyper-restrictive diets that elevate cortisol, focus on balanced blood sugar management—pairing complex carbohydrates with high protein, healthy fats, and fiber, similar to the strategies in our guide on 7 tips for eating with pelvic conditions.

3. Vetting Your Care Team

Be cautious of predatory providers who use the complexity of metabolic health to market expensive, unproven cure-alls or proprietary supplement kits. To protect your investment and health, review our warning guide on red flags in women’s hormonal health care.

Advocating for Accurate Care

Understanding the distinction between PCOS and PMOS validates what millions of women have felt for years: your condition is not “all in your head,” nor is it simply a minor ovarian glitch that can be solved with a quick prescription for birth control.

By recognizing PMOS as a primary metabolic disorder with ovarian manifestations, you can partner with knowledgeable, evidence-based clinicians, request the proper metabolic testing, and implement interventions that protect your fertility, metabolic stability, and long-term health.